title: Maprotiline and pulmonary alveolitis.
authors.forename: S
authors.initials: S
authors.lastname: Salmeron
authors.forename: F
authors.initials: F
authors.lastname: Brenot
authors.forename: B
authors.initials: B
authors.lastname: Rain
authors.forename: M
authors.initials: M
authors.lastname: Peuchemaur
authors.forename: P
authors.initials: P
authors.lastname: Herve
authors.forename: G
authors.initials: G
authors.lastname: Simonneau
authors.forename: P
authors.initials: P
authors.lastname: Duroux
authors.forename: B
authors.initials: B
authors.lastname: Rouveix
mesh_terms: D000368:Aged; D000873:Anthracenes / Q000009:adverse effects*; D004342:Drug Hypersensitivity / Q000209:etiology*; D006801:Humans; D008297:Male; D008376:Maprotiline / Q000009:adverse effects*; D011658:Pulmonary Fibrosis / Q000139:chemically induced*
chemical_list: D000873:Anthracenes; D008376:Maprotiline